Satu Mustjoki

74PUBLICATIONS
381CO-AUTHORS
Haematological tumoursAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Oct 09, 2026
RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

|Aug 25, 2026
International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Jun 23, 2026
Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT.

|Apr 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

|Mar 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.

Linus Wahnschaffe, Dennis Jungherz, Tony A Müller

Pageof 13

Frequent Collaborators

16 joint publications

Jani Huuhtanen

12 joint publications

Tero Aittokallio

12 joint publications

Matti Kankainen

10 joint publications

Oscar Brück